ArticlePharmaceutics2022

Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.

Jin-Bon Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.